穿孔性胃潰瘍の治療方法:ランダム化制御試験のネットワークメタ解析
Elisabeth Wadewitz1, Juliane Friedrichs1, Maurizio Grilli2
1Department of Visceral, Vascular and Endocrine Surgery, University Hospital Halle (Saale), Martin Luther University Halle Wittenberg, Halle, Germany.
Langenbeck's archives of surgery
|September 5, 2025
まとめ
腹腔鏡手術は,開いた手術と比較して, perforated peptic ulcer (PPU) の死亡率と合併症を著しく減少させます. このネットワークメタアナリシスは 腹腔鏡をPPUの黄金標準治療法として確認しました
科学分野:
- 胃腸科と外科革新
- 比較効果の研究
- 証拠 に 基づく 医学
背景:
- 穿孔性胃潰瘍 (PPU) は,かなりの罹病率と死亡率を持つ重要な外科的緊急事態を表します.
- PPUの最適な治療戦略は,現在進行中の臨床的議論と研究の対象となっています.
- 患者の治療結果を改善するために 異なる外科的アプローチの比較効果を評価することが重要です
研究 の 目的:
- 穿孔性胃潰瘍 (PPU) の外科治療と代替治療を比較するネットワークメタ解析 (NMA) を実施する.
- PPU患者の死亡率および他の主要な臨床結果に対する異なる治療戦略の影響を評価する.
- PPUの管理のための証拠に基づいた勧告を策定する.
主な方法:
- 複数の電子データベース (PubMed,Embase,Cochrane Libraryなど) の体系的な検索 関連するランダム化制御試験 (RCT) について
- ネットワークメタアナリシス (NMA) フレームワークは,PRISMAのガイドラインに従って,含まれている研究からデータを合成します.
- 標準化された平均差 (SMD) を用いた結果の分析 連続データとバイナリデータに対するオッズ比 (OR) を用いた結果の分析 95%信頼区間 (CI)
主要な成果:
- NMAには1,259人の患者を対象とした16件の研究が含まれていた.
- laparoscopic手術は,オープン手術と比較して著しく低い死亡率を示した (OR 0. 36, 95% CI 0. 17- 0. 75).
- ラパロスコープによるアプローチは,傷口感染 (OR 0. 15,95%CI 0. 08- 0. 27),および骨 (OR 0. 33,95%CI 0. 18- 0. 59) を含む術後の合併症の有意な減少を示した.
結論:
- ネットワークメタ解析は,PPUのオープン手術よりも腹腔鏡手術の優位性を支持する強力な証拠を提供します.
- 腹腔鏡手術は,死亡率と合併症の減少に基づいて, perforated 胃潰瘍の黄金標準治療法として確認されています.
- PPUの代替治療方法に関する証拠は,現在,決定的な結論を導き出すには不十分です.
関連する概念動画
Peptic Ulcer Disease IV: Management
144
Medical treatment strategies for peptic ulcers encompass various methods. The primary goal of treatment is to diminish gastric acidity and strengthen mucosal defense mechanisms.
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current...
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current...
144
Peptic Ulcer Disease V: Surgical Management and Nursing Care
403
Surgical management and nursing care are crucial in treating Peptic Ulcer Disease (PUD). Here is an organized and enhanced overview of the surgical interventions and the associated nursing care for PUD:
Surgical Interventions for Peptic Ulcer Disease
Surgical Interventions for Peptic Ulcer Disease
403
Drugs for Peptic Ulcer Disease: Prostaglandin Analogs as Mucosal Protective Agents
595
The gastric mucosa produces prostaglandins E2 (PGE2) and prostacyclin (PGI2), crucial in maintaining gastric health. They exert cytoprotective effects, including increasing bicarbonate secretion, releasing protective mucin, reducing gastric acid output, and preventing harmful vasoconstriction. These effects are mediated through various receptors, such as EP1, EP2, EP3, and EP4.
Non-steroidal anti-inflammatory drugs (NSAIDs) can induce peptic ulcers by inhibiting cyclooxygenase, decreasing...
Non-steroidal anti-inflammatory drugs (NSAIDs) can induce peptic ulcers by inhibiting cyclooxygenase, decreasing...
595
Treating Helicobacter pylori in Peptic Ulcers: Antimicrobial Therapy
546
Helicobacter pylori, a resilient gram-negative bacterium, can thrive in the stomach's harsh, acidic environment. Infection with H. pylori leads to a cascade of events within the stomach lining. One of the critical disruptions caused by this bacterium is the interference with somatostatin production, a hormone responsible for regulating acid secretion. This interference tips the balance, escalating acid secretion and diminishing bicarbonate levels. This imbalance compromises the defensive...
546
Peptic Ulcer Disease II: Pathophysiology
821
Peptic Ulcer Disease (PUD) is characterized by the development of ulcers in the stomach or duodenal mucosa. Its pathophysiology is complex, involving a balance between damaging and protective elements.
Damaging agents such as Helicobacter pylori, gastric acid, pepsin, and nonsteroidal anti-inflammatory drugs (NSAIDs) can weaken the mucosal defense, allowing hydrogen ions to infiltrate back and harm epithelial cells.
Damaging agents such as Helicobacter pylori, gastric acid, pepsin, and nonsteroidal anti-inflammatory drugs (NSAIDs) can weaken the mucosal defense, allowing hydrogen ions to infiltrate back and harm epithelial cells.
821
Peptic Ulcer Disease I: Introduction
282
Peptic Ulcer Disease (PUD) is characterized by mucosal excavation in the esophagus, stomach, pylorus, or duodenum. It can manifest as acute or chronic based on the extent and duration of mucosal involvement.
An acute ulcer, marked by superficial erosion and minimal inflammation, swiftly resolves upon identifying and addressing the underlying cause. In contrast, a chronic ulcer persists, potentially eroding through the muscular wall and forming fibrous tissue.
Peptic ulcers can also be...
An acute ulcer, marked by superficial erosion and minimal inflammation, swiftly resolves upon identifying and addressing the underlying cause. In contrast, a chronic ulcer persists, potentially eroding through the muscular wall and forming fibrous tissue.
Peptic ulcers can also be...
282


